Ng, Kok Pin
Chong, Joanna Su Xian
Lussier, Firoza
Therriault, Joseph
Rahmouni, Nesrine
Savard, Melissa
Stevenson, Jenna
Pascoal, Tharick
Gauthier, Serge
Rosa-Neto, Pedro
Zhou, Juan Helen
Funding for this research was provided by:
Weston Brain Institute, Canadian Institutes of Health Research (MOP-11-51-31; RFN 152985, 159815, 162303)
Canadian Consortium of Neurodegeneration and Aging (MOP-11-51-31 -team 1)
The Alzheimer’s Association (NIRG-12-92090, NIRP-12-259245)
Brain Canada Foundation (CFI Project 34874; 33397)
The Fonds de Recherche du Québec – Santé (Chercheur Boursier, 2020-VICO-279314)
Singapore National Medical Research Council (NMRC/OFLCG19May-0035, NMRC/CIRG/1485/2018, NMRC/CSA-SI/0007/2016, NMRC/MOH-00707-01, NMRC/CG/435 M009/2017-NUH/NUHS, CIRG21nov-0007, HLCA23Feb-0004 and OFIRG24Jul-0049)
A*STAR, Singapore (RIE2020 AME Programmatic Fund No. A20G8b0102)
Ministry of Education - Singapore (MOE-T2EP40120-0007 and T2EP2-0223-0025, MOE-T2EP20220-0001)
National University of Singapore (Yong Loo Lin School of Medicine Research Core Funding)
Article History
Received: 22 July 2025
Accepted: 27 January 2026
First Online: 10 February 2026
Declarations
:
: The study was approved by the Douglas Mental Health University Institute Research Ethics Board and Montreal Neurological Instituted PET working committee, and written informed consent was obtained from all participants before the start of the study.
: Not applicable.
: The authors declare no competing interests.